Medical & healthcare apps of REMS - Erythropoiesis Stimulating Agents (ESA) are listed with us

REMS - Erythropoiesis Stimulating Agents (ESA)

Erythropoiesis-stimulating agents (ESAs) are produced using recombinant DNA technologies. They were initially developed as replacement therapy to treat anemia due to endogenous erythropoietin deficiency that commonly occurs in individuals with chronic renal failure (CRF) secondary to CKD.